Recombinant Human CXCL5/ ENA-78 (5-78 a.a.)
Code | Size | Price |
---|
LEI-E151-25ug | 25 ug | £580.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Further Information
Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) containing BSA as a carrier protein pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) containing BSA as a carrier protein pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
C-X-C motif chemokine 5 (CXCL5), also known as ENA-78 and SCYB5, is an inflammatory chemokine that belongs to the CXC chemokine family. It is a potent chemotaxin involved in neutrophil activation and is expressed in monocytes, platelets, endothelial cells and mast cells (1). CXCL5 elicits biological activities by signaling through the cell surface chemokine receptor CXCR2 (2). It has been shown to be cleaved by MMP-12 at the ELR sequence motif, which is known to be the critical receptor binding motif (3). CXCL5 is produced concomitantly with IL-8 in response to stimulation with either IL-1 or TNFα and can be induced by exposure to bacterial LPS (4, 5). Expression of CXCL5 has been observed in eosinophils and can be inhibited with the type II interferon IFN-γ. It is expressed by epithelial cells within colorectal mucosa and has been implicated in Crohn's disease and ulcerative colitis (6). CXCL5 is important in growth and development of colorectal cancer, implicating a future role in both cancer therapy and diagnosis (7). CXCL5 has also been associated with connective tissue remodeling (2).
NCBI Gene:
6374
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
CXCL5
References
1. Strieter, RM. et al. (2005) Cytokine Growth Factor Rev. 16:593
2. Persson, T. et al. (2003) Clin. Exp. Allergy 33:531
3. Dean, RA. et al. (2008) Blood 112:3455
4. Chang, MS. et al. (1994) J. Biol. Chem. 269:25277
5. Rajashekhar, G. et al. (2007) Physiol. Genomics 31:104
6. W?gs?ter, D. et al. (2007) Internatl. J. Oncol. 31:97
7. Nagelkerke, F. et al. (2008) Clin. Cancer Res. 14:2276
Related Products
Product Name | Product Code | Supplier | Anti-Human CXCL5 (Clone 33160) | LEI-C1386 | Leinco Technologies | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-Mouse CXCL5 (Clone 61905) | LEI-C1414 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Human CXCL5 (Clone 33170) | LEI-C1607 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Human CXCL5 | LEI-E106 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant Human CXCL5 | LEI-E109 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Human CXCL5-Biotin | LEI-E122 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant Mouse CXCL5 | LEI-L123 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Mouse CXCL5 | LEI-L138 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recombinant Rat CXCL5 | LEI-L198 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Rat CXCL5 (Clone 135803) | LEI-L217 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Rat CXCL5 | LEI-L221 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Rat CXCL5 - Biotin | LEI-L231 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||